140 related articles for article (PubMed ID: 36445289)
21. Carcinoma ex pleomorphic adenoma of the salivary glands: distinct clinicopathologic features and immunoprofiles between subgroups according to cellular differentiation.
Kim JW; Kwon GY; Roh JL; Choi SH; Nam SY; Kim SY; Cho KJ
J Korean Med Sci; 2011 Oct; 26(10):1277-85. PubMed ID: 22022178
[TBL] [Abstract][Full Text] [Related]
22. Desmoplasia in different degrees of invasion of carcinoma ex-pleomorphic adenoma.
de Araújo VC; Furuse C; Cury PR; Altemani A; Alves VA; de Araújo NS
Head Neck Pathol; 2007 Dec; 1(2):112-7. PubMed ID: 20614261
[TBL] [Abstract][Full Text] [Related]
23. Carcinoma ex-pleomorphic adenoma derived from recurrent pleomorphic adenoma shows important difference by array CGH compared to recurrent pleomorphic adenoma without malignant transformation.
Mariano FV; Giovanetti K; Saccomani LF; Del Negro A; Kowalski LP; Krepischi AC; Altemani A
Braz J Otorhinolaryngol; 2016; 82(6):687-694. PubMed ID: 26971045
[TBL] [Abstract][Full Text] [Related]
24. Identification of differentially expressed microRNAs as potential biomarkers for carcinoma ex pleomorphic adenoma.
Kim H; Eun S; Jeong WJ; Ahn SH; Bae YJ; Lee JS; Kim H
Sci Rep; 2022 Aug; 12(1):13383. PubMed ID: 35927424
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of a subset of tumor suppressor gene for copy number and epigenitic changes in pleomorphic adenoma and carcinoma ex-pleomorphic adenoma carcinogenesis.
Mariano FV; Egal ES; Pramio D; Fidalgo F; Sara É; Costa AF; de Oliveira Gondak R; Coletta RD; de Almeida OP; Kowalski LP; Victorino Krepischi AC; Altemani A
Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 Sep; 122(3):322-31. PubMed ID: 27544395
[TBL] [Abstract][Full Text] [Related]
26. The Difference in the Clinical Features Between Carcinoma ex Pleomorphic Adenoma and Pleomorphic Adenoma.
Seok J; Hyun SJ; Jeong WJ; Ahn SH; Kim H; Jung YH
Ear Nose Throat J; 2019 Sep; 98(8):504-509. PubMed ID: 31189352
[TBL] [Abstract][Full Text] [Related]
27. Cytological features of carcinoma ex pleomorphic adenoma of the salivary glands: A diagnostic challenge.
Okano K; Ishida M; Sandoh K; Fujisawa T; Iwai H; Tsuta K
Diagn Cytopathol; 2020 Feb; 48(2):149-153. PubMed ID: 31675185
[TBL] [Abstract][Full Text] [Related]
28. Absence of myoepithelial cells correlates with invasion and metastasis of Carcinoma ex pleomorphic adenoma.
Ye P; Gao Y; Wei T; Yu GY; Peng X
Int J Oral Maxillofac Surg; 2017 Aug; 46(8):958-964. PubMed ID: 28431798
[TBL] [Abstract][Full Text] [Related]
29. Carcinoma ex-pleomorphic adenoma of upper lip showing copy number loss of tumor suppressor genes.
Mariano FV; Rincon D; Gondak RO; Jorge R; Lopes MA; Altemani A; de Almeida OP; Kowalski LP
Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 Jul; 116(1):69-74. PubMed ID: 23510689
[TBL] [Abstract][Full Text] [Related]
30. Soluble E-cadherin: a critical oncogene modulating receptor tyrosine kinases, MAPK and PI3K/Akt/mTOR signaling.
Brouxhon SM; Kyrkanides S; Teng X; Athar M; Ghazizadeh S; Simon M; O'Banion MK; Ma L
Oncogene; 2014 Jan; 33(2):225-35. PubMed ID: 23318419
[TBL] [Abstract][Full Text] [Related]
31. Carcinoma ex pleomorphic adenoma: pathologic analysis of 73 cases.
Lewis JE; Olsen KD; Sebo TJ
Hum Pathol; 2001 Jun; 32(6):596-604. PubMed ID: 11431714
[TBL] [Abstract][Full Text] [Related]
32. Carcinoma ex pleomorphic adenoma in a minor salivary gland of the upper lip.
McNamara ZJ; Batstone M; Farah CS
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Nov; 108(5):e51-3. PubMed ID: 19836713
[TBL] [Abstract][Full Text] [Related]
33. Comparison of Ki-67, cyclin E, and p63 in benign and malignant human pleomorphic adenoma.
Zhu X; Zhang J; Chen X; Feng X
Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 May; 113(5):667-72. PubMed ID: 22668626
[TBL] [Abstract][Full Text] [Related]
34. Carcinoma ex pleomorphic adenoma of the submandibular gland: A retrospective analysis of 86 patients.
Liu S; Lu H; Liu L; Wu Y; Zhu Y; Xu W; Yang W; Zhang C
Oral Dis; 2023 May; 29(4):1602-1612. PubMed ID: 35199423
[TBL] [Abstract][Full Text] [Related]
35. Dysregulation of the Rb pathway in recurrent pleomorphic adenoma of the salivary glands.
de Souza AA; Altemani A; Passador-Santos F; Turssi CP; de Araujo NS; de Araújo VC; Soares AB
Virchows Arch; 2015 Sep; 467(3):295-301. PubMed ID: 26155914
[TBL] [Abstract][Full Text] [Related]
36. Peroxiredoxin I, platelet-derived growth factor A, and platelet-derived growth factor receptor alpha are overexpressed in carcinoma ex pleomorphic adenoma: association with malignant transformation.
Demasi AP; Furuse C; Soares AB; Altemani A; Araújo VC
Hum Pathol; 2009 Mar; 40(3):390-7. PubMed ID: 18992915
[TBL] [Abstract][Full Text] [Related]
37. Carcinoma ex pleomorphic adenoma of the palate composed of invasive micropapillary salivary duct carcinoma and adenoid cystic carcinoma components: an unusual case with immunohistochemical approach.
Sedassari BT; da Silva Lascane NA; Tobouti PL; Pigatti FM; Franco MIF; de Sousa SCOM
Medicine (Baltimore); 2014 Dec; 93(27):e146. PubMed ID: 25501054
[TBL] [Abstract][Full Text] [Related]
38. Prognostic factors affecting the clinical outcome of carcinoma ex pleomorphic adenoma in the major salivary gland.
Zhao J; Wang J; Yu C; Guo L; Wang K; Liang Z; Lou J
World J Surg Oncol; 2013 Aug; 11(1):180. PubMed ID: 23924064
[TBL] [Abstract][Full Text] [Related]
39. Increased MIB-1 expression in salivary gland pleomorphic adenoma that recurs and undergoes malignant transformation.
Markkanen A; Aro K; Laury AR; Mäkitie AA; Haglund C; Atula T; Hagström J
Sci Rep; 2022 May; 12(1):9029. PubMed ID: 35637257
[TBL] [Abstract][Full Text] [Related]
40. Loss of BAP1 Protein Expression by Immunohistochemistry in the Salivary Duct Carcinoma Component of an Intracapsular Carcinoma ex Pleomorphic Adenoma of the Parotid Gland.
Quiroga EF; Connor PR; Rooper L; Moreno MA; Nix JS
Head Neck Pathol; 2023 Sep; 17(3):851-854. PubMed ID: 37594632
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
